Health

Moderna said in the coming weeks it would ask regulators in the U.S. and Europe to authorize two small-dose shots for youngsters under 6.

The Chester County practices were once affiliated with Tower Health, owner of the now-shuttered Jennersville and Brandywine hospitals.

The company warned of several tainted lots of Accuretic and two other versions of the drug due to the presence of a nitrosamine above the Acceptable Daily Intake level.

Fifteen states have enacted or are currently considering laws that would restrict medical treatments to more than 58,000 transgender youth.

Congress’s decision to exclude funding for coronavirus testing, vaccine and treatment in its government spending bill goes into effect Tuesday.

A boost in funds and flexibility in how food is prepped and packaged was a lifeline for hungry kids. But these measures, passed in response to COVID, expire in June.

In Pennsylvania, a growing number of divorced parents are taking their COVID vaccine disputes to court.

The rise of the more infectious BA.2 variant in the U.S. — plus signals in the sewage — also point to a possible uptick in cases, and have health officials on alert.

A Delaware County Memorial nurse called the announcement by Crozer Health a frightening development.

States and health providers report they've dispensed less than half their supply from the government, raising fears that the drugs may go to waste.

The request Thursday is broader than rival pharmaceutical company Pfizer’s request earlier this week for the regulator to approve a booster shot for all seniors.

The White House has warned it will run out of money to cover COVID-19 tests, treatments, and vaccines unless Congress approves additional spending.

The two Pennsylvania hospitals would be among 35 shake-ups nationwide, according to the Veterans Affairs secretary’s Asset and Infrastructure Review report.

Drugmaker Pfizer is expected to request authorization this week for an additional COVID-19 booster dose for seniors, according to a person familiar with the matter.

Penn researcher Drew Weissman spent decades developing mRNA technology. He says it helps target the rapidly mutating human immunodeficiency virus.